MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Cognitive dysfunction"

  • MDS Virtual Congress 2020

    SYNGAP1-related intellectual disability with ataxia and late onset of epileptic seizures

    N. Gogatishvili, T. Tkemaladze, V. Skrahina, S. Kasradze, A. Rolfs (Tbilisi, Georgia)

    Objective: To characterize seizures in a patient with SYNGAP1 mutation and the efficacy of antiepileptic drugs (AEDs). Background: SYNGAP1-related intellectual disability is characterized by developmental…
  • MDS Virtual Congress 2020

    Low Educational Level and Wilson’s disease: A direct path to cognitive decline

    J. Lima, F. Rolim, A. Gomes, A. Marinho, V. Mesquita, G. Ferreira, F. Carvalho (Fortaleza, Brazil)

    Objective: To assess cognitive profile of Wilson's Disease (WD) patients in a single tertiary Movement Disorders center in Fortaleza, Ceará, Brazil. Background: WD is an autosomal recessive disorder…
  • MDS Virtual Congress 2020

    Preclinical pharmacology and early clinical development of dopamine D1 positive allosteric modulators (D1PAMs) with therapeutic potential for neuropsychiatric disorders

    K. Svensson, H. Meltzer, K. Biglan (Indianapolis, IN, USA)

    Objective: The objective was to characterize novel dopamine D1PAMs pre-clinically in behavioral and neurochemical models and in phase 1 human studies in healthy volunteers and…
  • MDS Virtual Congress 2020

    The dual cognitive syndrome in Parkinson’s disease: volumetric, morphological and tractometric features

    Q. Devignes, R. Viard, R. Lopes, N. Betrouni, G. Kuchcinski, G. Carey, L. Defebvre, A. Leentjens, K. Dujardin (Lille, France)

    Objective: To assess volumetric, morphological and tractometric features associated with the fronto-striatal and posterior cortical cognitive profiles in Parkinson’s Disease (PD) Background: The dual syndrome…
  • MDS Virtual Congress 2020

    Predicting dementia in the first 6 years of Parkinson’s disease in the ICICLE-PD cohort

    R. Lawson, C. William-Gray, M. Camacho, G. Duncan, T. Khoo, D. Breen, R. Barker, L. Rochester, D. Burn, A. Yarnall (Newcastle upon Tyne, United Kingdom)

    Objective: To determine which baseline cognitive tests in newly diagnosed participants with Parkinson’s disease (PD) predict conversion to dementia (PDD) within six years. Background: Cognitive…
  • MDS Virtual Congress 2020

    Exploring the role of the retrograde procedural memory in PD in the Luxembourg Parkinson’s Disease Study

    L. Pauly, C. Pauly, G. Hipp, M. Hansen, V. Schröder, R. Krüger (Belvaux, Luxembourg)

    Objective: Deepening knowledge of retrograde procedural memory (RPM) in typical Parkinson’s Disease (PD) patients to demonstrate that RPM is impaired in patients with PD. Background:…
  • MDS Virtual Congress 2020

    Candidate plasma miRNAs and EV protein as novel biomarkers in Parkinson’s disease patients with cognitive impairment and dementia

    R.M Wu, Y.Z Tsai, M.C Kuo, Y.u Yoshioka, K.j Ueda, T.k Ochiya, S.P Lin (Taipei, Taiwan)

    Objective: To determine the diagnostic value of circulating miRNAs and the extracellular vesicle proteins for early detection of patients with Parkinson’s disease and mild cognitive…
  • MDS Virtual Congress 2020

    Graph theory analysis of dopamine D2 receptor network in Parkinson’s disease patients

    A. Mihaescu, J. Kim, S. Cho, M. Diez-Cirarda, M. Valli, Y. Koshimori, A. Strafella (Toronto, ON, Canada)

    Objective: The aim of this study was to explore a novel method of analyzing positron emission tomography (PET) data using graph theory analysis. To this…
  • MDS Virtual Congress 2020

    Dysphasia as a novel approach for classification of speech disorders in Parkinson’s disease and other forms of neurodegeneration

    E. Vasenina, O. Levin (Moscow, Russian Federation)

    Objective: To classify and identify the features of speech disorders in Parkinson's disease and other neurodegenerative diseases. Background: No unified approach to classification and diagnostics…
  • MDS Virtual Congress 2020

    Measure of Social Relation in Huntington’s Disease: The Relationship Self-Questionnaire (RSQ)

    J. Hamet Bagnou, R. Massart, K. Hernandez, R. Fliss, M. Lunven, E. Audureau, A.C Bachoud-Levi (Creteil, France)

    Objective: Development and validation of the Relationship Self-Questionnaire (RSQ), specific to Huntington’s disease (HD), which aims tomeasurepatients self-perceived quality of their relationships (RS). Background: In…
  • « Previous Page
  • 1
  • …
  • 62
  • 63
  • 64
  • 65
  • 66
  • …
  • 128
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Welcome to the MDS Abstracts Site
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • #24970 (not found)
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley